The applicant brings strong computational pharmacology, neuroscience modeling, and AI‑driven drug‑resistance expertise, which aligns with the neuropharmacology aspects of the fellowship. However, the posting emphasizes a traditional molecular biology background and a completed PhD, which the applicant does not yet possess, limiting overall suitability.